Vimarsana
Biggest News Aggregation in the World

Page 5 - Scott Struthers News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Scott Struthers. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Scott Struthers Today - Breaking & Trending Today

Sanders Morris Harris LLC Invests $336,000 in Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) - Vimarsana News

Sanders Morris Harris LLC Invests $336,000 in Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX)

Sanders Morris Harris LLC acquired a new position in Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Free Report) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund acquired 18,600 shares of the company’s stock, valued at approximately $336,000. A number of other institutional investors and […]

Sanders Morris Harris LLC Acquires New Shares in Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) - Vimarsana News

Sanders Morris Harris LLC Acquires New Shares in Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX)

Sanders Morris Harris LLC acquired a new stake in Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Free Report) in the second quarter, according to its most recent filing with the SEC. The fund acquired 18,600 shares of the company’s stock, valued at approximately $336,000. Other hedge funds have also bought and sold shares of the company. Tower […]

Source: wkrb13.com
HC Wainwright Reaffirms "Buy" Rating for Crinetics Pharmaceuticals (NASDAQ:CRNX) - Vimarsana News

HC Wainwright Reaffirms "Buy" Rating for Crinetics Pharmaceuticals (NASDAQ:CRNX)

HC Wainwright reaffirmed their buy rating on shares of Crinetics Pharmaceuticals (NASDAQ:CRNX – Free Report) in a research note released on Monday, Benzinga reports. HC Wainwright currently has a $33.00 price objective on the stock. A number of other equities research analysts have also weighed in on the stock. Cantor Fitzgerald restated an overweight rating […]

Source: wkrb13.com
Evercore ISI Increases Crinetics Pharmaceuticals (NASDAQ:CRNX) Price Target to $48.00 - Vimarsana News

Evercore ISI Increases Crinetics Pharmaceuticals (NASDAQ:CRNX) Price Target to $48.00

Crinetics Pharmaceuticals (NASDAQ:CRNX – Free Report) had its price objective boosted by Evercore ISI from $41.00 to $48.00 in a research note published on Monday morning, MarketBeat Ratings reports. They currently have an outperform rating on the stock. CRNX has been the topic of a number of other research reports. Cantor Fitzgerald reaffirmed an overweight […]

Crinetics Pharmaceuticals' (CRNX) Buy Rating Reiterated at HC Wainwright - Vimarsana News

Crinetics Pharmaceuticals' (CRNX) Buy Rating Reiterated at HC Wainwright

HC Wainwright reiterated their buy rating on shares of Crinetics Pharmaceuticals (NASDAQ:CRNX – Free Report) in a research report report published on Monday, Benzinga reports. The firm currently has a $33.00 price target on the stock. Other equities analysts have also recently issued research reports about the stock. JMP Securities cut their price objective on […]